Abstract
Introduction: The development of wound infections is the most common cause of mortality and morbidity among burn patients. A variety of dressings have been used to cover and reduce burn wound sepsis and promote wound healing. The aim of the present study was to examine the effectiveness of composite and judicious use of different stem cell-rich pregnancy-specific biological substances (PSBS) such as freshly collected amniotic membrane, amniotic fluid, and the placenta in case of extensive burn wound.
Materials and methods: Patients with more than 20% wound were admitted, and options were given for conservative management with PSBS dressing at a nonteaching hospital or provided with referral facility at the burns unit of another tertiary-level government hospital. Those who opted for treatment with PSBS (procured from hepatitis-, syphilis- and HIV-seronegative mothers having undergone cesarean deliveries) were treated initially at Bejoygarh State Hospital (1999–2006) and the same regimen was followed later at Vidyasagore Hospital (2006–2009). The area affected included both partial to complete thickness thermal burns. Patients suffering from chemical burns, or burned areas in sensitive parts of the body such as the genitals or face, were also included in this study from 1999 to 2009.
Result and analysis: Initially, 97 patients were randomly recruited for the present study of the utility of PSBS in the burn management. Of these, 33 patients, who did not agree to the PSBS protocol, were transferred to the burn unit of a tertiary-care hospital and were treated with broad spectrum antibiotics, application of silver sulfadiazine cream with electrolytes, and other supportive drugs to combat initial shock and infection till the patient was fit for autologous skin graft.
The rest, i.e., 64 burn patients (male 24, age 2–96 years, mean 36 ± 5.4 years and female 40, age 7–68 years, mean 32 ± 5.7 years) with 26–76% of total body surface area calculated on the basis of the famous rule of nine were enrolled in the present study for PSBS treatment (1999–2009).
Patients were treated with placenta (Step 1). After washing the burn site initially with normal saline, it was followed by gentle rubbing of the burned area with a freshly collected placenta’s maternal attachment site as a dressing material. This move may have a positive cytokine impact on the process of healing. Then, the burn site was washed with freshly collected amniotic fluid as a cell therapy source (because of its rich content of epithelial and mesenchymal stem cell component, leaving aside its antibacterial propensity as a helpful adjuvant) (Step 2). At last amniotic membrane is applied at the affected area (Step 3), as a temporary biological wound cover to expedite the healing and also to reduce the exudation, pain, and infection at the burn wound site with judicious application mode, i.e., chorionic side to augment vasculogenesis in early wound and the amniotic side to promote epithelialization lately. This is an effective step to augment the cell therapy component of the amniotic fluid.
Conclusion: The globally used skin substitutes currently available are costly and many are not universally available. The easily available and simple utilization of the biological waste generated from obstetric wards for the burn victims is very effective and rewarding. Use of stem cell-rich PSBS regimen has a profound regenerative impact in case of burn irrespective of the degree of burn. Its wider application is recommended on the basis of our experience of the present study, which has been carried out for 10 years (1999–2009).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sanghavi P, Bhalla K, Das V. Fire Related Deaths in India in 2001: A Retrospective Analysis of Data. Lancet. 2009;373(9671):1282–1288.
Rudolph R, Ballantyne DL Jr. Skin grafts. In: McCarthy JG, ed. Plastic Surgery, vol. 1. 1st ed. Philadelphia, PA: W.B. Saunders; 1990:221-274.
Akle CA, Adinolfi M, Welsh KI, Leibowitz S, McColl I. Immunogenicity of human amniotic epithelial cells after transplantation into volunteers. Lancet. 1981;2(8254):1003-1005.
Hori J, Wang M, Kamiya K, Takahashi H, Sakuragawa N. Immunological characteristics of amniotic epithelium. Cornea. 2006;25(10 suppl 1):S53-S58.
Pruit BA, Lindberg RB. Pseudomonas aeruginosa infection on burn patients. In: Doggett RG, ed. Pseudomonas aeruginosa: Clinical Manifestations of Infection and Current Therapy. 1st ed. New York: Academic; 1979:339-366.
Bose B. Burn wound dressing with human amniotic membrane. Ann R Coll Surg Engl. 1979;61:447-444.
Ramakrishnan KM, Jayaraman V. Management of partial-thickness burn wounds by amniotic membrane: a cost effective treatment in developing countries. Burns. 1997;23(suppl):33-36.
Sharma SC, Bagree MM, Bhat AL, et al. Amniotic membrane is an effective burn dressing material. Jpn J Surg. 1985;15:140-143.
Kim JS, Kim JC, Na BK, et al. Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn. Exp Eye Res. 2000;70:327-329.
Lynch JB. Thermal burns. In: Smith JW, Aston SJ, eds. Grabb and Smith Plastic Surgery. 3rd ed. Boston, MA: Little Brown & Company; 1979:453-575.
Eaglestein WH. Experience with biosynthetic dressings. J Am Acad Dermatol. 1985;12:434-440.
Moritz AR, Henriques FC. Studies of thermal injuries. II. The relative importance of time and surface temperature in the causation of cutaneous burns. Am J Pathol. 1947;23:695-720.
Biswas TK, Auddy B, Bhattacharya NP, Bhattacharya S, Mukherjee B. Wound healing property of human placental extracts in rats. Acta Pharmacol Sin. 2001;22(12):1113-1116.
Tiwary SK, Shukla D, Tripathi AK, Agrawal S, Singh MK, Shukla VK. Effect of placental-extract gel and cream on non-healing wounds. J Wound Care. 2006;15(7):325-328.
Chandanwale A, Langade D, Mohod V, et al. Comparative evaluation of human placental extract for its healing potential in surgical wounds after orthopaedic surgery: an open, randomised, comparative study. J Indian Med Assoc. 2008;106(6):405-408.
De Coppi P, Bartsch G Jr, Siddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007;25:100-106.
Miki T, Lehmann T, Cai H, et al. Stem cell characteristics of amniotic epithelial cells. Stem Cells. 2005;23:1549-1559.
Ilancheran S, Michalska A, Peh G, et al. Stem cells derived from human fetal membranes display multi-lineage differentiation potential. Biol Reprod. 2007;77:577-588.
Portmann-Lanz CB, Schoeberlein A, Huber A, et al. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am J Obstet Gynecol. 2006;194:664-673.
Kakishita K, Nakao N, Sakuragawa N, et al. Implantation of human amniotic epithelial cells prevents the degeneration of nigral dopamine neurons in rats with 6-hydroxydopamine lesions. Brain Res. 2003;980:48-56.
Miki T, Lehmann T, Cai H, et al. Stem cell characteristics of amniotic epithelial cells. Stem Cells. 2005;23:1549-1559.
Takashima S, Ise H, Zhao P, et al. Human amniotic epithelial cells possess hepatocyte-like characteristics and functions. Cell Struct Funct. 2004;29:73-84.
Alviano F, Fossati V, Marchionni C, et al. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol. 2007;7:11.
Sakuragawa N, Kakinuma K, Kikuchi A, et al. Human amnion mesenchyme cells express phenotypes of neuroglial progenitor cells. J Neurosci Res. 2004;78:208-214.
Soncini M, Vertua E, Gibelli L, et al. Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med. 2007;1:296-305.
ibid 25
Zhao P, Ise H, Hongo M, et al. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation. 2005;79:528-535.
Wei JP, Zhang TS, Kawa S, et al. Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice. Cell Transplant. 2003;12:545-552.
ibid 28
Parolini O, Alviano F, Bagnara GP, et al. Isolation and characterization of cells from human term placenta. Stem Cells. 2008;26:300-311.
Lu LL, Liu YJ, Yang SG, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica. 2006;91:1017-1026.
Nelson JL. Microchimerism and autoimmune disease. N Engl J Med. 1998;338:1224-1225.
Khosrotehrani K, Bianchi DW. Fetal cell microchimerism: helpful or harmful to the parous woman? Curr Opin Obstet Gynecol. 2003;15:195-199.
Khosrotehrani K, Bianchi DW. Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse. J Cell Sci. 2005;118:1559-1563.
Khosrotehrani K, Johnson KL, Guégan S, et al. Natural history of fetal cell microchimerism during and following murine pregnancy. J Reprod Immunol. 2005;66:1-12.
Tan XW, Liao H, Sun L, et al. Fetal microchimerism in the maternal mouse brain: a novel population of fetal progenitor or stem cells able to cross the blood-brain barrier? Stem Cells. 2005;23:1443-1452.
Khosrotehrani K, Reyes RR, Johnson KL, et al. Fetal cells participate over time in the response to specific types of murine maternal hepatic injury. Hum Reprod. 2007;22:654-666.
Bianchi DW, Zickwolf GK, Weil GJ, et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA. 1996;93:705-708.
Bhattacharya N. Fetal cell/tissue therapy in adult disease: a new horizon in regenerative medicine. Clin Exp Obstet Gynecol. 2004;31(3):167-173.
Bhattacharya N, Chhetri MK, Mukherjee KL, et al. Can human fetal cortical brain tissue transplant (up to 20 weeks) sustain its metabolic and oxygen requirements in a heterotopic site outside the brain? A study of 12 volunteers with Parkinson’s disease. Clin Exp Obstet Gynecol. 2002;29(4):259-266.
Bhattacharya N, Chhetri MK, Mukherjee KL, et al. Human fetal adrenal transplant: a possible role in relieving intractable pain in advanced rheumatoid arthritis. Clin Exp Obstet Gynecol. 2002;29(3):197-206.
Bhattacharya N. Fetal tissue/organ transplant in HLA-randomized adult vascular subcutaneous axillary folds: preliminary report of 14 patients. Clin Exp Obstet Gynecol. 2001;28(4):233-239.
Bhattacharya N, Mukherjee KL, Chettri MK, et al. A unique experience with human pre-immune (12 weeks) and hypo-immune (16 weeks) fetal thymus transplant in a vascular subcutaneous axillary fold in patients with advanced cancer: a report of two cases. Eur J Gynaecol Oncol. 2001;22(4):273-277.
Acknowledgment
The Department of Science and Technology, Government of West Bengal, supported the investigator with a research grant during his tenure at Bijoygarh State Hospital from 1999 to 2006.The author gratefully acknowledges the support of the patients who volunteered for this research work. The guidance of Prof K. L. Mukherjee (Biochemistry) and Prof M. K. Chhetri, former Director of Health Services is also acknowledged.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer London
About this chapter
Cite this chapter
Bhattacharya, N. (2011). Use of Amniotic Membrane, Amniotic Fluid, and Placental Dressing in Advanced Burn Patients. In: Bhattacharya, N., Stubblefield, P. (eds) Regenerative Medicine Using Pregnancy-Specific Biological Substances. Springer, London. https://doi.org/10.1007/978-1-84882-718-9_37
Download citation
DOI: https://doi.org/10.1007/978-1-84882-718-9_37
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84882-717-2
Online ISBN: 978-1-84882-718-9
eBook Packages: MedicineMedicine (R0)